Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-08-29
1988-01-05
Brown, J. R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514801, 514855, A61K 3144
Patent
active
047177276
ABSTRACT:
Esters of pyridine-2,4- and -2,5-dicarboxylic acid act as inhibitors of proline hydroxylase and lysine hydroxylase and are suitable as fibrosuppressants and immunosuppressants, in particular for the treatment of disturbances of the metabolism of collagen and collagen-like substances and of the biosynthesis of Cl.sub.q.
REFERENCES:
patent: 2809146 (1957-10-01), Osborn et al.
patent: 2852519 (1958-09-01), Kruse
patent: 4457936 (1984-07-01), Draeger et al.
Burger's Medicinal Chemistry, 4th ed., Part II, Ed. by M. Wolff, pp. 1242-1244, 1978.
Muller et al., "Reversible Inhibition of ClQ Release from Guinea Pig Microphages by 2,2'-Dipyridyl".
Majamaa et al., "The 2-Oxoglutarate Binding Site of Prolyl 4-Hydroxylase.
Gunzler et al., "Influence of the Posttransitional Hydroxylation Step on the Secretion of Cl9, a Subcomponent of the First Component of a Complement by Macrophages".
Pliml, Synthetic Analogs of Curare Alkaloids, Chemical Abstracts 9665 f, 1955.
Brocks Dietrich
Gunzler Volkmar
Hanauske-Abel Hartmut
Kivirikko Kari
Majamaa Kari
Brown J. R.
Hoechst Aktiengesellschaft
Rollins Jr. John W.
LandOfFree
Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-9282